Amber Brauer-Nikonow

The paper identifies gut bacteria that convert drugs into prodrugs, increasing systemic drug exposure and altering pharmacokinetics.

This study identifies riboflavin production by vaginal lactobacilli and shows its role in modulating host immune responses and redox balance.

This study develops a high-throughput in vitro pipeline to quantify epithelial permeability of gut bacterial metabolites and identifies new bacteria-drug pairs affecting permeability.

This study identifies nitroxoline's broad antibacterial activity against Gram-negative bacteria, its mode of action involving metal homeostasis and outer membrane disruption, and resistance mechanisms across multiple species.

This study reveals interindividual variability in gut microbial metabolism of immunosuppressive drugs mediated by specific bacterial species and enzymes.

The paper introduces a high-throughput glycoproteomics method to quantify brain glycoproteome changes induced by gut microbiome composition.